Eskayef Pharmaceuticals Ltd.

Eskayef Pharmaceuticals Limited
Private Limited
Industry Pharmaceutical
Founded 1990 (1990)
Headquarters Gulshan, Dhaka, Bangladesh
Website skfbd.com

Eskayef Pharmaceuticals Limited, also known as SK+F, is a pharmaceutical company based in Bangladesh. It is part of the Transcom Group.[1][2] Simeen Hossain is the managing director & CEO of the company.[2][3]

History

Eskayef Bangladesh Limited (SK+F), a successor of Smith, Kline & French in Bangladesh, was acquired by Transcom in 1990.[2] According to a 2008 survey by Intercontinental Marketing Services, the company placed among the top ten pharmaceutical companies operating in Bangladesh in terms of sales.[4] As of 2015, it exported its products to 21 countries across 4 continents, and had annual sales surpassing 128 million US dollars.[2] The company was renamed Eskayef Pharmaceuticals Limited in January 2017.[5]

The company is engaged in the manufacture and marketing of a wide range of therapeutic drugs, bulk pellets and animal health and nutrition products.[6]

References

  1. ↑ Iqbal, Farah K. (2016-09-19). "What makes the market tick?". Dhaka Tribune (Op-ed). Retrieved 2016-10-03.
  2. 1 2 3 4 "Eskayef sales jump manifold". The Daily Star. 2015-12-29. Retrieved 2016-10-03.
  3. ↑ "'I am the brand'". Prothom Alo. Retrieved 2016-10-03.
  4. ↑ Akter, Sayeda (2009-08-23). "Pharma industry set for expansion". The Daily Star. Retrieved 2016-10-03.
  5. ↑ "Eskayef pledges to conquer odds with courage". The Daily Star. 2017-01-24.
  6. ↑ "Eskayef beats rivals in sales growth". The Daily Star. 2012-01-26.

Further reading

  • Rahman, Md Fazlur (2015-03-24). "Novo Nordisk: Ethically profitable". The Daily Star. Retrieved 2016-10-03.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.